Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-12-16
1996-09-24
Travers, Russell
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514262, A61K 3152
Patent
active
055591140
ABSTRACT:
A method for treating autoimmune disease in a mammalian subject, particularly a human, which method comprises administering a therapeutically effective amount of certain 2-amino purine compounds to the subject. The compounds particularly useful are antiviral compounds exemplified by acyclovir, penciclovir and famciclovir. The compounds are administered at doses significantly higher than the dose level used to treat viral infections, e.g., doses that will result in blood plasma levels of about 3-10 micrograms/mi.
REFERENCES:
patent: 4199574 (1980-04-01), Schaeffer
patent: 4221794 (1980-09-01), Simon et al.
patent: 4853386 (1989-08-01), Friebe et al.
patent: 5059604 (1991-10-01), Krenitsky et al.
patent: 5075445 (1991-12-01), Jarvest et al.
patent: 5098906 (1992-03-01), Sircar et al.
patent: 5246937 (1993-09-01), Harnden et al.
patent: 5250688 (1993-10-01), Harnden et al.
Adour et al., (1984) "Current Medical Treatment for Facial Palsy" The American Journal of Otology 5:499-502.
Baethge et al., (1989) "Case Report: Herpes Zoster Myelitis Occurring During Treatment for Systemic Lupus Erythematosus" The American Journal of the Medical Sciences 298:264-266.
Lycke et al., (1989) "Acyclovir Concentrations in Serum and Cerebrospinal Fluid at Steady State" Journal of Antimicrobial Chemotherapy 24:947-954.
Shelley et al., (1989) "Essential Progressive Telangiectasia in an Autoimmune Setting: Successful Treatment with Acyclovir" J. Am. Acad. Dermatol 21:1094-1096.
Harrison et al., (1993) "Acyclovir in Rheumatoid Arthritis" The Journal of Rheumatology 20:761-762.
Feinman et al., (1993) "Central Nervous System Herpesvirus Infection in Systemic Lupus Erythematosus: Diagnosis by Endoretinal Biopsy" The Journal of Rheumatology 20:1058-1061.
LandOfFree
Treatment of autoimmune disease using 2-amino purine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of autoimmune disease using 2-amino purine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of autoimmune disease using 2-amino purine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1928575